ABS Bio News & Announcements

  • January 6, 2026

    ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery

  • July 9, 2025

    ABS Bio Appoints Ehab Alramahy as President & CEO

  • May 13, 2025

    ABS Bio appoints two industry leaders to Board of Directors

  • April 29, 2025

    ABS Bio welcomes Libu Mathew, CPA as Chief Financial Officer

  • March 26, 2025

    ABS Bio receives accreditation from the College of American Pathologists (CAP)

  • February 25, 2025

    ABS Bio to exhibit at Precision Med Tri-Con Conference in San Diego

  • December 5, 2024

    ABS Bio, Inc. Launches Refreshed Brand Identity

  • November 14, 2024

    ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital